Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1987-12-8
|
pubmed:abstractText |
Serum HDL cholesterol, apolipoproteins AI and AII and post heparin lipolytic activities (PHLA) have been measured in a group of fourteen hypothyroid women without ovarian oestrogen secretion before and during a 2-month thyroxine treatment. The more rapid and consistent observed event was a decrease in apo AI levels (164 +/- 5 vs. 149 +/- 5 mg dl-1, mean +/- SEM, P less than 0.05) correlated (r = 0.79, P less than 0.05) to a slight increment of PHLA. A slight decrease in apo AII concentration was seen only after 5 days (25 +/- 2 vs. 22 +/- 2 mg dl-1, P less than 0.05) and in HDL cholesterol only after 60 days (1.3 +/- 0.6 vs. 1.1 +/- 0.5 mmol 1-1, P less than 0.05). Apo AI, HDL2 and HDL3 cholesterol were measured in another group of seven hypothyroid postmenopausal women before and after a 2-month thyroxine treatment. We observed a decrease in HDL2 cholesterol (1.69 +/- 0.20 vs. 1.17 +/- 0.09 mmol 1-1, P less than 0.02) with no changes in HDL3 cholesterol (0.88 +/- 0.09 vs. 0.99 +/- 0.06 mmol 1-1, NS). The decrease in HDL2 cholesterol correlated (r = 0.72, P = 0.05) with that for apo AI. The differential influence of thyroxine (T4) administration on the major HDL components might reflect changes in HDL composition due to the multiple effects of thyroid hormones on lipid metabolism. It can be hypothesized that the decrease in apo AI and HDL2 cholesterol concentrations are due, at least in part, to the increase in hepatic lipase activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-II,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins A,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, HDL2,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, HDL3,
http://linkedlifedata.com/resource/pubmed/chemical/Thyroxine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0014-2972
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
313-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3117568-Adolescent,
pubmed-meshheading:3117568-Adult,
pubmed-meshheading:3117568-Aged,
pubmed-meshheading:3117568-Aged, 80 and over,
pubmed-meshheading:3117568-Apolipoprotein A-I,
pubmed-meshheading:3117568-Apolipoprotein A-II,
pubmed-meshheading:3117568-Apolipoproteins A,
pubmed-meshheading:3117568-Cholesterol, HDL,
pubmed-meshheading:3117568-Female,
pubmed-meshheading:3117568-Humans,
pubmed-meshheading:3117568-Hypothyroidism,
pubmed-meshheading:3117568-Lipoproteins, HDL,
pubmed-meshheading:3117568-Lipoproteins, HDL2,
pubmed-meshheading:3117568-Lipoproteins, HDL3,
pubmed-meshheading:3117568-Middle Aged,
pubmed-meshheading:3117568-Thyroxine
|
pubmed:year |
1987
|
pubmed:articleTitle |
Time-course of alterations of high density lipoproteins (HDL) during thyroxine administration to hypothyroid women.
|
pubmed:affiliation |
Service d'Endocrinologie et des maladies, de la Nutrition, Unité INSERM 197, Hôpital de l'Antiquaille, Lyon, France.
|
pubmed:publicationType |
Journal Article
|